These findings reveal a novel crosstalk mechanism between circRNAs and tumor macrophages that promote Kras-driven lung immunosuppressive metastasis and can serve as a potential therapeutic target for NSCLC. This evidence concerns the gene KRAS and non-small cell lung carcinoma.